Humoral Immune Responses to EGFR-Derived Peptides Predict Progression-Free and Overall Survival of Non-Small Cell Lung Cancer Patients Receiving Gefitinib.

Autor:	Azuma, Koichi1 azuma@med.kurume-u.ac.jp, Komatsu, Nobukazu2, Hattori, Satoshi3, Matsueda, Satoko2, Kawahara, Akihiko4, Sasada, Tetsuro2, Itoh, Kyogo2, Hoshino, Tomoaki1
Zdroj:	PLoS ONE. Jan2014, Vol. 9 Issue 1, p1-7. 7p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu